Fact-checked by Grok 2 weeks ago

HEPES

HEPES, or 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, is a zwitterionic buffering agent with the molecular formula C8H18N2O4S and a molecular weight of 238.31 g/. It serves as a biological primarily used to maintain physiological in cell culture media and biochemical experiments, with a pKa of 7.55 at 20°C that enables effective buffering in the range of 6.8 to 8.2. As one of the original introduced in , HEPES exhibits low UV absorbance, minimal reactivity with metal ions, high water solubility, and reduced sensitivity to CO2 fluctuations compared to traditional buffers. Developed by Norman E. Good and colleagues to address limitations in existing buffers for biological research, HEPES was selected for its stability under physiological conditions and suitability for studies involving enzymes, proteins, and living cells. Its zwitterionic nature contributes to low membrane permeability, preventing unintended cellular uptake, while its heat resistance and resistance to oxidation-reduction reactions make it reliable for various lab protocols. However, HEPES can generate upon light exposure, necessitating dark storage, and it may interfere with certain assays like the Folin protein determination or redox-sensitive reactions due to radical formation. In practice, HEPES is employed in short-term cell manipulations such as passaging, , and drug treatments, as well as in , activity assays, and nucleic acid hybridizations where stable is critical. It is particularly valued in for and , offering advantages over other buffers like Tris in maintaining during CO2-exposed incubations.

Chemical Properties

Molecular Structure and Nomenclature

HEPES, or 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, is the systematic IUPAC name for this buffering agent. Its molecular formula is C₈H₁₈N₂O₄S, and it has a molecular weight of 238.30 g/mol. The molecular structure of HEPES features a central ring, a six-membered heterocyclic ring containing two atoms at positions 1 and 4. One atom is substituted with a hydroxyethyl group (-CH₂CH₂OH), providing a hydroxyl that contributes to hydrogen bonding capabilities. The other is attached to an ethanesulfonic acid group (-CH₂CH₂SO₃H), which includes a moiety essential for its acidic properties. This arrangement of tertiary nitrogens and ionizable groups allows HEPES to exist predominantly in a zwitterionic form at physiological pH, with the acting as the anion and one as the cation. A textual representation of the structure can be depicted as follows, highlighting the key functional groups:
      HO-CH₂-CH₂-N¹
         |  
         N⁴-CH₂-CH₂-SO₃H
         /   \
       CH₂     CH₂
         \   /
         CH₂-CH₂
In this schematic, N¹ and N⁴ denote the piperazine ring nitrogens, with the hydroxyethyl and ethanesulfonic acid substituents emphasized for clarity. The sulfonate (-SO₃H), hydroxyl (-OH), and tertiary amines are the primary functional groups influencing its chemical behavior.

Physical Characteristics

HEPES is typically observed as a white to off-white crystalline , facilitating its handling and storage in environments. It is odorless, ensuring no interference from volatile compounds during experimental procedures. The compound exhibits a of approximately 234–238 °C, at which it decomposes rather than forming a stable . HEPES has a density of about 1.4 g/cm³ for the form. It demonstrates high in , exceeding 400 g/L at 20 °C, but shows poor in and acetone, and is insoluble in non-polar solvents, reflecting its polar zwitterionic character. As a hygroscopic , HEPES readily absorbs moisture from the air, which can affect its purity and performance if not stored properly in desiccated conditions.

Acid-Base Behavior

HEPES functions as a buffering agent through the and deprotonation of its nitrogen atom, which has a of 7.5 at 25 °C. This value enables effective buffering over a range of 6.8 to 8.2, which encompasses physiological conditions relevant to many biological systems. The group remains deprotonated across this range due to its much lower (approximately 3), contributing to the molecule's zwitterionic nature. The acid-base equilibrium of HEPES is governed by the reversible protonation of the piperazine ring: \text{HEPESH}^{+} \rightleftharpoons \text{HEPES} + \text{H}^{+} Here, HEPESH⁺ represents the cationic form with the protonated piperazine and deprotonated sulfonate, while HEPES is the zwitterionic form with neutral piperazine and deprotonated sulfonate; this pair acts as the conjugate acid-base system responsible for buffering. The pKa of HEPES exhibits a temperature dependence characterized by ΔpKa/ΔT ≈ -0.014/°C, resulting in a relatively small shift in buffering capacity with temperature changes compared to many traditional buffers. This stability arises from the zwitterionic structure, which minimizes enthalpic contributions to the dissociation. Ionic strength has a modest effect on the of HEPES, with the reported value of 7.55 measured at an ionic strength of 0.1; increases in ionic strength typically cause minor decreases in due to changes in ion activity coefficients, but the impact is less pronounced than for non-zwitterionic buffers.

Preparation and Use

Chemical Synthesis

HEPES was first synthesized in by Good and colleagues as part of their development of zwitterionic buffers suitable for biological applications. The primary laboratory synthesis of HEPES involves a reaction between N-(2-hydroxyethyl) and sodium 2-chloroethanesulfonate in an aqueous or alcoholic medium. The nitrogen acts as the , displacing the chloride to form the ethanesulfonate linkage on the ring. Reaction conditions require precise control of temperature, time, and molar ratios of reactants (typically 1:1.1 to 1.2) to minimize side reactions such as bis-substitution, with the mixture often heated to 50–80°C for several hours. Following the substitution, the reaction mixture is acidified with to protonate the and yield the free acid form of HEPES, with reported yields ranging from 70% to 90%. Purification of the crude product is achieved through recrystallization from water- mixtures, where the HEPES is dissolved in hot aqueous , decolorized with if needed, and then cooled to induce , resulting in purity exceeding 99%. Additional steps may include to remove byproducts and vacuum drying to obtain the final white crystalline solid. Alternative multi-step syntheses start from , which is first mono-substituted with in to form N-(2-hydroxyethyl)piperazine, often requiring excess piperazine or protection of one amine (e.g., via temporary ) to favor mono-substitution. The resulting N-(2-hydroxyethyl)piperazine then undergoes with sodium 2-chloroethanesulfonate, prepared from and , in or under (60–115°C) for 2–4 hours, with maintained at 9–10 using NaOH. This route can achieve yields of approximately 85–94% after ion-exchange purification or for salt removal, concentration, and crystallization.

Buffer Solution Preparation

HEPES buffer solutions are typically prepared from commercially available HEPES free acid or its salts, with stock concentrations often made at 1 M for dilution into working buffers. To prepare a 1 M HEPES stock solution at pH 7.5, dissolve 23.83 g of HEPES free acid in approximately 80 mL of deionized water, then titrate the pH to 7.5 using 10 M NaOH while stirring and monitoring with a pH meter calibrated at the desired temperature (typically 25°C), which usually requires about 4–5 mL of the base before diluting to a final volume of 100 mL with deionized water. This method ensures the buffer is approximately 50% in the protonated and deprotonated forms, given HEPES's pKa of 7.5 at 25°C, making it ideal for physiological pH ranges. Working concentrations for experimental use, particularly in , are commonly 10–25 mM, achieved by diluting the 1 M stock into the appropriate medium or , followed by pH adjustment at the intended working temperature (e.g., 37°C for mammalian applications) since the pKa of HEPES decreases by about 0.014–0.018 units per °C increase. Higher concentrations up to 50 mM may be used in some assays but should be tested for compatibility to avoid osmotic stress. For sterilization, HEPES solutions can be autoclaved at 121°C for 15–20 minutes if prepared without heat-sensitive components, though through a 0.22 μm sterile is preferred to prevent potential degradation or precipitation, especially in complex media. High heat should be avoided when possible, as prolonged exposure above 100°C may lead to minor breakdown products. Variants of HEPES buffers can be made using sodium or salts to meet specific ionic requirements; for example, the sodium salt (HEPES sodium) is dissolved directly in and adjusted with HCl if needed, providing Na⁺ ions suitable for many biological systems, while the salt offers K⁺ for potassium-sensitive experiments. HEPES is commercially available as the free acid (e.g., H3375) or sodium salt (e.g., H7006), often in high-purity grades for biochemical use, facilitating straightforward preparation without custom synthesis.

Stability and Storage

HEPES in its solid form exhibits high stability when stored under dry conditions at (15–30 °C) in airtight containers to prevent absorption, remaining viable indefinitely without significant . from light is recommended, as prolonged exposure can initiate minor oxidative changes, though the powder maintains its free-flowing nature and performance characteristics for extended periods. In solution, HEPES buffers maintain pH stability for several months when refrigerated at , but their longevity is compromised by sensitivity to microbial if not sterilized, such as through or autoclaving where compatible. exposure, particularly UV or fluorescent light, induces photooxidation, leading to the formation of and other reactive species that cause minor and potential in biological applications. Temperature elevation above 60 °C accelerates degradation in solutions, while interaction with transition metals like iron or can promote radical formation, such as HEPES radicals via or superoxide addition, further destabilizing the buffer. The typical shelf life for HEPES powder is 2–3 years from manufacture when stored properly, whereas prepared solutions have a shorter span of 6–12 months under refrigerated, dark conditions to minimize degradation risks. Handling precautions include wearing gloves to prevent contamination from skin oils or salts, and solutions should be discarded if they show cloudiness, particulates, or color changes indicative of deterioration.

Biological and Biochemical Applications

Role in Cell Culture

HEPES serves as a vital buffering agent in media, typically supplemented at concentrations of 10–25 mM to counteract fluctuations caused by cellular metabolic activity or exposure to ambient air. This supplementation enhances the stability of the culture environment, particularly during manipulations outside controlled incubators. A key advantage of HEPES in is its independence from CO2, allowing stable pH maintenance without the need for a 5–10% CO2 atmosphere required by bicarbonate-based systems. This feature is especially beneficial in standard incubators or during short-term procedures where CO2 levels may vary. HEPES demonstrates broad compatibility and is generally non-toxic to mammalian, , and cells at recommended concentrations (10-25 mM), particularly when protected from light to prevent H2O2 formation and associated . It is commonly incorporated into media such as DMEM and RPMI-1640. For mammalian cells, it supports viability without adverse effects under proper conditions, while reports confirm its use in insect cell lines like AmE-711 and plant studies involving cultures. In specialized applications, HEPES facilitates cultures and primary cell isolation, particularly in scenarios where precise CO2 control is difficult, such as during tissue dissociation or transport. In , HEPES is used in (ICSI) protocols for manipulation, though studies suggest buffers may further reduce stress for improved development (as of 2024). A concentration of 20 mM is often optimal for maintaining physiological levels of 7.2–7.4, aligning with HEPES's effective buffering range near its of 7.5.

Use in Enzymatic and Molecular Assays

HEPES is widely employed in enzymatic assays to maintain stable conditions during kinetic studies, typically at concentrations of 20–50 mM, where it supports accurate measurement of activities without significant interference. For instance, in assays, HEPES buffers at 25 mM 7.4 facilitate the of peptide substrates by enzymes such as myosin regulators. Similarly, assays utilize 20 mM HEPES at 7.5 to evaluate rates of specific phosphoproteins, enabling high-throughput quantification of activity in purified systems. In metal-dependent , HEPES at 7.6 often yields optimal catalytic efficiency compared to other buffers like Tris or . In techniques, HEPES is incorporated into buffers to stabilize and enhance reaction specificity, particularly in quantitative where it improves when combined with Tris. For native (PAGE), HEPES-based running buffers (e.g., 1X HEPES system) minimize gradients, preserving protein native structures during separation of complexes like proteins or RNA折叠. In protocols, HEPES at 20–50 mM serves as a and equilibration buffer, supporting steps by maintaining physiological without disrupting ionic interactions. HEPES exhibits low interference in these assays due to its minimal UV above 230 nm, allowing reliable spectrophotometric of reactions without background noise, and it lacks significant of divalent cations such as Ca²⁺ or Mg²⁺, preserving cofactor availability. This inertness is particularly advantageous in fluorescence-based assays, where HEPES ensures stability critical for probes like HPTS in intracellular dynamics. Specific applications include isothermal amplification methods, where HEPES maintains optimal conditions in () variants for detection, akin to its role in diagnostics. In protocols, HEPES is often supplemented with salts like NaCl to adjust , enhancing buffer compatibility with assay components while leveraging its inherent solution stability.

Additional Scientific Applications

HEPES has found applications in nanoparticle synthesis, where it serves as both a reducing and capping agent for the formation of and silver nanoparticles. In a modified one-pot , HEPES facilitates the seedless, silver-assisted growth of branched nanostars from HAuCl₄ without additional reductants, enabling control over and size for plasmonic applications. Similarly, HEPES acts as a mild in the disproportionation synthesis of nanoparticles, capping the surfaces to stabilize structures like spheres and rods. These properties stem from HEPES's ability to donate electrons and interact amphiphilically with metal surfaces, promoting uniform and preventing aggregation. In electrochemical studies, HEPES is employed as a in the development of biosensors, maintaining stable physiological conditions during functionalization and analyte detection. For instance, aptamer-based electrochemical sensors for or TNF-α are equilibrated and tested in 20 mM HEPES ( 7.4–7.5) to ensure reliable impedance or voltammetric responses in serum-mimicking environments. Additionally, HEPES participates in radical scavenging s, where its trapping capability is quantified electrochemically; the itself scavenges and s, influencing outcomes in Fenton reaction-based setups. This dual role enhances the fidelity of electrochemical measurements for activity and monitoring. Beyond these, HEPES supports applications in and . In , it is used for ⁶⁸Ga labeling of peptides for (PET) imaging, where HEPES buffers (pH 4–5) facilitate chelator-free or DOTA-mediated complexation, achieving high radiochemical yields (>95%) while minimizing cold metal impurities; recent evaluations (2024) affirm its safety for intravenous administration with no at doses up to 100 mg/kg in animal models. In experiments, HEPES acts as a grinding and superfusion to stabilize in tissue extracts and maintain osmolality during ion flux or activity assays, such as those studying stomatal responses or . Emerging uses include organ-on-chip (OoC) devices and media, leveraging HEPES's CO₂-independent buffering for dynamic microenvironments. In OoC platforms modeling intestine or multi-organ systems, HEPES (10–30 mM, pH 7.4) supplements to counteract pH shifts from fluid or , enabling long-term culture of epithelial barriers under . For , HEPES is incorporated into bioinks and post-printing solutions (e.g., 50 mM with CaCl₂ crosslinkers) to preserve viability during extrusion of neural or vascular tissues, as seen in pectin-collagen hydrogels for models. A unique property of HEPES is its surfactant-like behavior at interfaces, arising from its zwitterionic structure and low , which promotes and stabilizes emulsions or thin films. This is evident in aqueous two-phase systems induced by HEPES, where simulations reveal its amphiphilic orientation at solvent interfaces, aiding applications like cryo-EM grid preparation by enhancing distribution and stability.

Advantages, Limitations, and Comparisons

Benefits Over Traditional Buffers

HEPES offers a value of 7.5 at 25°C, closely matching physiological levels around 7.4, which enables more effective buffering in biological systems compared to Tris, with a pKa of 8.1 that provides suboptimal capacity at neutral pH. This proximity to physiological conditions minimizes perturbations during experiments involving living cells or enzymes. Unlike buffers, which experience significant fluctuations due to atmospheric CO2 exchange in open systems, HEPES maintains stable without requiring a controlled CO2 , simplifying experimental setups in and assays. Its zwitterionic structure contributes to this independence, ensuring consistent performance under ambient conditions. HEPES demonstrates high , characterized by low to mammalian cells, negligible permeation at physiological , and no substantial with metabolic pathways or enzymatic activities, outperforming traditional buffers like that can form insoluble precipitates or chelate metals. Additionally, its low absorbance in the UV-Vis range (below 230 ) supports accurate spectrophotometric measurements without background , a common issue with aromatic or inorganic buffers. The buffer's versatility stems from its across a wide range of temperatures (with a low ΔpKa/ΔT of -0.014) and ionic strengths, reducing the need for frequent adjustments in diverse experimental conditions, in contrast to Tris's higher temperature sensitivity (-0.031 ΔpKa/ΔT). This robustness makes HEPES particularly valuable in applications requiring thermal variability or varying salt concentrations.

Potential Drawbacks

Despite its widespread use, HEPES possesses several inherent limitations that can impact its suitability in certain experimental contexts. The ring structure of HEPES is prone to generating free radical , particularly under to UV light or oxidative conditions such as those involving ions and . This radical formation can interfere with redox-sensitive assays and biological systems by promoting unwanted oxidative reactions. HEPES is notably more expensive than traditional inorganic buffers like , which can increase costs in large-scale or routine applications. While exact multiples vary by supplier, the and purity requirements of HEPES contribute to its higher price point compared to simple salt-based alternatives. Although HEPES is often selected for its minimal interference with metal-dependent processes, it exhibits slight binding affinity to certain transition metals, such as forming a CuL+ complex with Cu(II). This weak can potentially sequester essential cofactors and inhibit enzymes that rely on these metals for activity, particularly in prolonged incubations. The buffering capacity of HEPES is optimized for the physiological range, with effective performance limited to approximately 6.8 to 8.2; below 6.8 or above 8.2, its ability to maintain stable diminishes significantly, making it unsuitable for experiments requiring broader acidity or alkalinity. From an environmental perspective, the moiety in HEPES requires careful disposal practices to avoid environmental release, as recommended in safety data sheets. HEPES shares key characteristics with other Good's buffers, including being zwitterionic, highly soluble in water, and exhibiting low toxicity to biological systems, which minimizes interference in biochemical reactions. These properties stem from the design criteria established for Good's series, emphasizing pKa values near physiological pH, minimal UV absorbance, and limited ionic strength effects. Compared to (pKa 6.1 at 25°C), (pKa 7.5 at 25°C) is better suited for higher ranges of 7–8, making it preferable for mammalian where physiological conditions around pH 7.4 are required, while excels in more acidic environments ( 6–7) such as bacterial or media. also offers greater (approximately 100 g/L in ) than (about 100 g/L), facilitating preparation of concentrated stock solutions. In relation to PIPES (pKa 6.8 at 25°C), HEPES provides a similar effective range but demonstrates lower metal ion due to its structural differences, reducing potential interference in metal-dependent enzymatic assays; , with its dual groups, is occasionally favored in plant histology studies for preserving tissue integrity during fixation. However, exhibits very low water solubility (approximately 1 g/L at 100°C free acid form), often requiring sodium salt variants for easier dissolution. Versus (pKa 7.2 at 25°C), HEPES shows greater against temperature fluctuations in certain applications, such as storage where shifts are minimized, although has a lower ΔpKa/dT coefficient (-0.006 °C⁻¹ versus -0.014 °C⁻¹ for HEPES), making it more suitable for experiments involving wide temperature variations; is generally more cost-effective for large-scale preparations. Both buffers maintain high , with at approximately 500 g/L and HEPES higher at over 400 g/L.
BufferpKa (25°C)Effective pH RangeΔpKa/dT (°C⁻¹)Water Solubility (g/L, approx.)Key Use Case Differentiation from HEPES
MES6.15.5–6.7-0.011100Acidic media; lower pH for non-mammalian cells
PIPES6.86.1–7.5-0.00851 (free acid)Plant histology; higher metal chelation potential
MOPS7.26.5–7.9-0.006500Temperature-variable experiments; cost-effective scaling
HEPES7.56.8–8.2-0.014>400Mammalian cell culture; physiological pH stability
Selection among these buffers depends on required , cost considerations, and experimental context; for instance, piperazine-based buffers like HEPES and should be avoided in redox-sensitive studies due to their propensity to form radicals under oxidative conditions.

Historical Development

Origins in Good's Buffer Series

HEPES was developed as part of a pioneering effort led by Norman E. Good and colleagues to create a new class of buffers optimized for biological research. In 1966, Good et al. published a seminal paper in Biochemistry introducing 12 zwitterionic buffers, collectively known as , which included HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid). This series was designed to overcome the shortcomings of traditional buffers like phosphate, which forms insoluble salts with divalent cations, and Tris, which exhibits significant pH sensitivity to changes. The design criteria for these buffers emphasized properties essential for physiological and biochemical studies: a in the range of 6.0–8.0 to align with cellular environments, solubility exceeding 0.5 M in , chemical and thermal stability, minimal effects, low interference with metal ions, and impermeability to biological membranes to avoid cellular . HEPES was specifically selected for its of approximately 7.5, which closely mimics the pH of intracellular and extracellular fluids, enabling precise pH control without perturbing biological systems. As one of the zwitterionic derivatives in the series, HEPES was synthesized to ensure high purity and consistency in buffering capacity. Initial evaluations of HEPES focused on its efficacy in organelle-based experiments, particularly in maintaining stable during chloroplast fragmentation and mitochondrial respiration assays. These early tests demonstrated HEPES's superior performance in sustaining photosynthetic and processes compared to conventional , highlighting its potential for advancing studies in . The naming and classification of HEPES as a Good's underscored its role within this family of N-substituted taurine-like compounds, though no specific patent for HEPES itself was filed by the researchers at the time.

Evolution and Widespread Adoption

Following its development as part of the Good's buffer series in 1966, HEPES experienced rapid uptake in biological research during the , particularly for maintaining stable in systems outside controlled CO2 environments. Early studies demonstrated its efficacy in promoting continuous of lymphocytoid lines when added to bicarbonate-buffered media, highlighting its practical advantages for long-term cultures. By the mid-, HEPES was integrated into commercial formulations, such as modifications of Dulbecco's Modified Eagle Medium (DMEM), enabling broader accessibility for laboratories transitioning from traditional systems. In 1972, Good and colleagues expanded the series with three additional buffers, further solidifying the framework for these specialized buffering agents. The and marked a surge in HEPES demand driven by the expansion of techniques in , coinciding with the rise of for production and intensive research into pathogenesis. These fields relied heavily on HEPES-buffered media to support stable conditions for hybridoma fusion, antibody screening, and viral propagation in immortalized cell lines, contributing to key advancements like the development of therapeutic monoclonal antibodies. The era's growth in R&D amplified HEPES's role, as its non-toxic profile at physiological concentrations facilitated high-yield cultures essential for scaling early biotech processes. From the 2000s onward, HEPES applications broadened beyond traditional into emerging areas like and , reflecting the interdisciplinary evolution of . In , it serves as a key component in calcium phosphate-mediated protocols for DNA delivery. In , HEPES buffers synthesis and assays, such as those involving gold nanoparticles for or cellular uptake experiments, due to its ability to prevent fluctuations during surface modifications. This expansion correlates with increased global production to meet rising demands in these high-precision fields. Regulatory frameworks have further solidified HEPES's adoption, with the FDA approving its use as an in injectable pharmaceuticals like ONIVYDE (liposomal ) for applications, affirming its safety profile under specific conditions. Manufacturing adheres to stringent purity standards, often aligned with ISO guidelines for biochemical reagents, ensuring minimal contaminants like or endotoxins for sensitive biotech processes. Today, HEPES remains indispensable in the biotech industry, appearing in thousands of peer-reviewed publications and underpinning routine protocols from to commercial production.